ZIKAllianceCH

Bolivia (Plurinational State of) Brazil Colombia Guadeloupe Mexico Venezuela (Bolivarian Republic of)
|
2018-2022
  • Adults (18-64 years)
  • General population
  • Infants (<1 year)
  • Children (1-11 years)
  • Pregnant women
  • Community
  • Arbovirus
  • Vector-borne disease
  • Zika virus
  • Blood sample
  • Urine sample
  • Hair
  • Saliva
  • Semen
  • Vaginal fluids

ZITOPEx

France
|
2023-2024
  • Pregnant women
  • Community
  • Arbovirus
  • Vector-borne disease
  • Zika virus
  • Venezuelan equine encephalitis virus

SwissPrEPared

Switzerland
|
2019-2022
  • Adults (18-64 years)
  • Elderly (≥65 years)
  • People at high risk of STIs
  • PrEP users
  • Hospital
  • Community
  • Primary care
  • Chlamydia trachomatis
  • Neisseria gonorrhoeae
  • Treponema pallidum
  • Pharmacological intervention
  • PrEP-bSTI

ChikRhuma15

France Réunion
|
2023-2025
  • Adults (18-64 years)
  • Elderly (≥65 years)
  • Community
  • Arbovirus
  • Chikungunya virus
  • Vector-borne

Doran

The Netherlands Curaçao
|
2015
  • Adults (18-64 years)
  • Elderly (≥65 years)
  • Community
  • Arbovirus
  • Chikungunya virus
  • Vector-borne

REUNION Study

France Réunion
|
2022
  • Adults (18-64 years)
  • Elderly (≥65 years)
  • Community
  • Arbovirus
  • Chikungunya virus
  • Vector-borne

CHIKGene

France Réunion
|
2005
  • Adults (18-64 years)
  • Elderly (≥65 years)
  • Community
  • Arbovirus
  • Chikungunya virus
  • Vector-borne

ITIT

Switzerland
|
2022-2025
  • Adults (18-64 years)
  • Elderly (≥65 years)
  • Travelers
  • Community
  • Telemedicine
  • Arbovirus
  • Chikungunya virus
  • Vector-borne
  • Dengue virus
  • West Nile virus
  • Non pharmacological intervention
  • Digital health

Bellmann-Strobl

Germany
|
2023-2025
  • Adults (18-64 years)
  • General population
  • Outpatient clinic
  • Community
  • Primary care
  • SARS-CoV-2
  • Post COVID-19 condition
  • Post-acute infection syndrome
  • Pharmacological intervention
  • vasodilator
  • Vericiguat

STWandRVD

Italy
|
2023-2023
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Community
  • SARS-CoV-2
  • Post COVID-19 condition
  • Post-acute infection syndrome
  • Non pharmacological intervention
  • Hydrotherapy

PCS TeR

Germany
|
2023
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Community
  • SARS-CoV-2
  • Post COVID-19 condition
  • Post-acute infection syndrome
  • Non pharmacological intervention
  • Rehabilitation